Hypertension+ pregnancy treatment
Reading File
Finding Sources
Searching PubMed
"hypertension" AND "pregnancy" AND "treatment"
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative sources. Let me compile the complete answer.
Hypertension in Pregnancy: Classification and Treatment
Classification
Hypertensive disorders of pregnancy are a spectrum:
| Category | Definition |
|---|---|
| Chronic hypertension | HTN present before 20 weeks or pre-existing |
| Gestational hypertension | New-onset HTN after 20 weeks, NO proteinuria; resolves within 3 months postpartum |
| Preeclampsia | New HTN (SBP ≥140 or DBP ≥90 mmHg) after 20 weeks + proteinuria (≥300 mg/24h) OR organ dysfunction |
| Eclampsia | Preeclampsia + seizures |
| Superimposed preeclampsia | Preeclampsia developing on top of chronic HTN |
Hypertension affects up to 10% of pregnant women. Preeclampsia occurs in ~5% of pregnancies. Approximately 15-25% of patients with gestational hypertension progress to overt preeclampsia.
Treatment Thresholds
- Severe HTN (SBP ≥160 or DBP ≥105-110 mmHg): drug therapy is clearly indicated - risk of stroke and cardiovascular complications is high.
- Mild-to-moderate HTN (SBP 140-159 / DBP 90-104): evidence is less definitive. The CHIPS trial showed no difference in adverse maternal/fetal outcomes between tight (DBP target 85 mmHg) vs. less-tight (DBP target 100 mmHg) control, but tight control reduced progression to severe HTN.
- Recommended BP target: 140-150 / 90-100 mmHg in the acute setting (not normalizing BP aggressively).
Drugs Safe in Pregnancy
Oral (Chronic / Outpatient Management)
| Drug | Starting Dose | Max Daily Dose | Notes |
|---|---|---|---|
| Methyldopa | 250 mg twice daily | 2000 mg | First-line; most extensive safety data; centrally acting α2-agonist; drawback: sedation, short half-life |
| Labetalol | 100-200 mg twice daily | 1200 mg | α1 + non-selective β-blocker; preferred over other β-blockers (preserves uteroplacental flow); avoid in reactive airway disease |
| Long-acting nifedipine | 30 mg once daily | 120 mg | Calcium channel blocker; once-daily dosing; side effect: edema, headache |
| Hydralazine (oral) | 50 mg three times daily | 300 mg | Second-line; direct vasodilator; side effect: reflex tachycardia |
Labetalol is often cited as the first-line agent for chronic HTN in pregnancy (Tintinalli's); methyldopa has the most historical safety data (Brenner & Rector, NKF Primer). Both are acceptable first-line choices.
Intravenous (Acute / Hypertensive Emergency)
| Drug | Dose | Notes |
|---|---|---|
| Labetalol IV | 20 mg IV; escalate to 40 mg at 10 min if inadequate | First-line IV agent |
| Hydralazine IV | 5 or 10 mg IV/IM; repeat every 20 min | Extensive experience; increased risk of maternal hypotension and placental abruption vs. labetalol |
| Nifedipine (sublingual/oral) | 10-30 mg PO | Not FDA-approved for this indication; used widely |
| Nicardipine IV | Infusion | Extensive safety data as tocolytic; effective |
| Sodium nitroprusside | Avoid >4 hours | Risk of fetal cyanide poisoning - last resort only |
Magnesium Sulfate - Seizure Prophylaxis
Magnesium sulfate is the standard of care for seizure prevention in severe preeclampsia and eclampsia. It is not an antihypertensive but has documented efficacy for seizure prevention with no adverse fetal effects.
- Indicated for: severe preeclampsia with CNS manifestations (headache, visual disturbances, altered mental status)
- Also indicated postpartum: ~20% of eclampsia episodes occur >48 hours after delivery
Contraindicated Drugs
| Drug Class | Reason |
|---|---|
| ACE inhibitors (e.g., lisinopril, enalapril) | Multiple fetal anomalies: renal dysplasia, oligohydramnios, pulmonary hypoplasia - especially in 2nd trimester |
| ARBs (e.g., losartan) | Same risks as ACE inhibitors - absolutely contraindicated |
| Atenolol | Associated with fetal growth restriction |
| Nitroprusside | Fetal cyanide toxicity if used >4 hours |
| Spironolactone | Theoretical risk of inadequate virilization of male fetuses (anti-androgenic) |
Diuretics are generally avoided as first-line agents because they may impair the physiologic plasma volume expansion of pregnancy; however, they can be used if needed for volume overload (not in preeclampsia).
Preeclampsia with Severe Features
Criteria for severe features include:
- SBP ≥160 or DBP ≥110 mmHg on 2 occasions ≥4 hours apart
- Thrombocytopenia (<100,000/mL)
- Impaired liver function (LFTs >2x normal, or persistent RUQ/epigastric pain)
- Progressive renal insufficiency (creatinine >1.1 mg/dL, or doubling without other cause)
- Pulmonary edema
- Cerebral or visual disturbances
Definitive Treatment
Delivery of the baby is the treatment of choice when severe preeclampsia occurs and the fetus is sufficiently mature. If the fetus is very preterm, hospitalization + pharmacotherapy may be employed to permit further fetal maturation in utero (along with corticosteroids for fetal lung maturity).
Special Considerations
- ACE inhibitors / ARBs: If a woman on these agents becomes pregnant, they should be stopped as soon as possible after conception.
- Secondary causes of HTN in pregnancy (renal artery stenosis, pheochromocytoma, primary hyperaldosteronism, OSA) should be considered, especially in severe/resistant cases.
- Mineralocorticoid receptor mutation: Rare; progesterone inappropriately activates the receptor, causing marked HTN exacerbation in pregnancy without proteinuria.
- Postpartum: Eclampsia can occur postpartum; continue Mg sulfate and antihypertensives as needed.
Recent Evidence (2025)
A 2025 network meta-analysis (PMID 40216176) compared oral antihypertensive regimens in pregnancy, providing updated comparative effectiveness data on labetalol, nifedipine, and methyldopa - consistent with current guidelines favoring these three agents.
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 95-103 | Brenner & Rector's The Kidney, p. 2160 | NKF Primer on Kidney Diseases 8e, p. 490 | Tintinalli's Emergency Medicine, p. 1624-1627 | Harrison's Principles of Internal Medicine 22E
Hypertension with diabetes
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
Hypertension with diabetes treatment
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.